Page last updated: 2024-12-06

pronarcon

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

pronarcon: RN given refers to cpd without isomeric designation; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID18735
CHEMBL ID92963
CHEBI ID81294
SCHEMBL ID77712
MeSH IDM0055704

Synonyms (31)

Synonym
pronarcon
enibomal
narcovene
chebi:81294 ,
CHEMBL92963
narcobarbital
5-(2-bromoprop-2-enyl)-1-methyl-5-propan-2-yl-1,3-diazinane-2,4,6-trione
C17722
125-55-3
narkotal
pronarkon
narcodorm
1-methyl-5-isopropyl-5-(2-bromoallyl)barbituric acid
5-(2-bromoallyl)-5-isopropyl-1-methylbarbituric acid
narcovene s
5-(2-bromoallyl)-1-methyl-5-isopropylbarbituric acid
barbituric acid, 5-(2-bromoallyl)-5-isopropyl-1-methyl-
5-(2-bromallyl)-5-isopropyl-1-methylbarbitursaeure
2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(2-bromo-2-propenyl)-1-methyl-5-(1-methylethyl)-
unii-a77u8g9h84
a77u8g9h84 ,
5-(2'-bromallyl)-5-isopropyl-1-methylbarbituric acid
enibomal [who-dd]
2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(2-bromo-2-propen-1-yl)-1-methyl-5-(1-methylethyl)-
narcobarbital [mi]
SCHEMBL77712
WGMASVSHOSNKMF-UHFFFAOYSA-N
DB13229
Q906241
5-(2-bromoprop-2-en-1-yl)-1-methyl-5-(propan-2-yl)-1,3-diazinane-2,4,6-trione
DTXSID30871609
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
barbituratesMembers of the class of pyrimidones consisting of pyrimidine-2,4,6(1H,3H,5H)-trione (barbituric acid) and its derivatives. Largest group of the synthetic sedative/hypnotics, sharing a characteristic six-membered ring structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID227701Anticonvulsant activity; NC denotes that compound is not classified2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199029 (93.55)18.7374
1990's1 (3.23)18.2507
2000's1 (3.23)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (2.86%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (97.14%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]